Log in
Enquire now
‌

Scripta Therapeutics

Scripta Therapeutics is a disease-modifying drugs discovery platform founded in 2025 by Peter Hamley.

OverviewStructured DataIssuesContributors

Contents

scriptatherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
CEO
‌
Peter Hamley
Founder
‌
Peter Hamley
Number of Employees (Ranges)
1 – 10
Email Address
hello@scriptatherapeutics.com
Investors
YZR Capital
YZR Capital
Oxford University Innovation
Oxford University Innovation
Apollo Ventures
Apollo Ventures
Parkwalk Advisors
Parkwalk Advisors
AlbionVC
AlbionVC
‌
Ray Barlow
Oxford Science Enterprises plc
Oxford Science Enterprises plc
Founded Date
2025
Total Funding Amount (USD)
12,000,000
Latest Funding Round Date
November 14, 2025
Latest Funding Type
Seed
Seed
Country
United Kingdom
United Kingdom
Headquarters
Oxford
Oxford

Other attributes

Latest Funding Round Amount (USD)
12,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Scripta Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.